Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RUTIH Trial
NCT02246270Phase 1Completed
- Sponsor
- University of Oklahoma
- Start
- Nov 2017
- Primary completion
- Dec 2025
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in urinary tract infection (UTI) comparing Intravesical heparin with Placebo (2 arms). Primary endpoint: Urinary Tract Infection rate at 6 months. Started Nov 2017; status: completed.
02
Drugs
heparin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT02246270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02246270.